{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:36:56Z","timestamp":1790699816145,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>NUT carcinoma (NC) is a type of aggressive cancer driven by chromosome translocations. Fusion genes between a DNA-binding protein, such as bromodomain and extraterminal domain (BET) proteins, and the testis-specific protein NUTM1 generated by these translocations drive the formation of NC. NC can develop in very young children without significant accumulation of somatic mutations, presenting a relatively clean model to study the genetic etiology of oncogenesis. However, after 20 years of research, a few challenging questions still remain for understanding the mechanism and developing therapeutics for NC. In this short review, we first briefly summarize the current knowledge regarding the molecular mechanism and targeted therapy development of NC. We then raise three challenging questions: (1) What is the cell of origin of NC? (2) How does the germline analogous epigenetic reprogramming process driven by the BET-NUTM1 fusion proteins cause NC? and (3) How will BET-NUTM1 targeted therapies be developed? We propose that with the unprecedented technological advancements in genome editing, animal models, stem cell biology, organoids, and chemical biology, we have unique opportunities to address these challenges.<\/jats:p>","DOI":"10.3390\/genes12020235","type":"journal-article","created":{"date-parts":[[2021,2,7]],"date-time":"2021-02-07T14:04:13Z","timestamp":1612706653000},"page":"235","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Challenges and Opportunities in NUT Carcinoma Research"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-2463","authenticated-orcid":false,"given":"Bin","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University East Lansing, MI 48824, USA"},{"name":"Department of Biomedical Engineering; Michigan State University East Lansing, MI 48824, USA"},{"name":"Institute for Quantitative Health Science and Engineering, Michigan State University East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell C.","family":"Hakun","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering; Michigan State University East Lansing, MI 48824, USA"},{"name":"Institute for Quantitative Health Science and Engineering, Michigan State University East Lansing, MI 48824, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cancergencyto.2010.06.007","article-title":"NUT midline carcinoma","volume":"203","author":"French","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00043426-199124000-00011","article-title":"Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19)","volume":"13","author":"Kees","year":"1991","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"key":"ref_3","first-page":"304","article-title":"BRD4-NUT fusion oncogene: A novel mechanism in aggressive carcinoma","volume":"63","author":"French","year":"2003","journal-title":"Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","article-title":"BRD-NUT oncoproteins: A family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells","volume":"27","author":"French","year":"2008","journal-title":"Oncogene"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","article-title":"NSD3-NUT fusion oncoprotein in NUT midline carcinoma: Implications for a novel oncogenic mechanism","volume":"4","author":"French","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/gcc.3","article-title":"CIC-NUTM1 fusion: A case which expands the spectrum of NUT-rearranged epithelioid malignancies","volume":"57","author":"Schaefer","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"E4184","DOI":"10.1073\/pnas.1702086114","article-title":"Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma","volume":"114","author":"Alekseyenko","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","article-title":"Midline carcinoma of children and young adults with NUT rearrangement","volume":"22","author":"French","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-pathol-011811-132438","article-title":"Pathogenesis of NUT midline carcinoma","volume":"7","author":"French","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mrrev.2008.05.004","article-title":"Many different tumor types have polyclonal tumor origin: Evidence and implications","volume":"659","author":"Parsons","year":"2008","journal-title":"Mutat. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2018.05.001","article-title":"Multiclonal tumor origin: Evidence and implications","volume":"777","author":"Parsons","year":"2018","journal-title":"Mutat. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2613.2000.00142.x","article-title":"The clonal origin and clonal evolution of epithelial tumours","volume":"81","author":"Garcia","year":"2000","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/annonc\/mdw686","article-title":"Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma","volume":"28","author":"Lee","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Eagen, K.P., and French, C.A. (2021). Supercharging BRD4 with NUT in carcinoma. Oncogene, in press.","DOI":"10.1038\/s41388-020-01625-0"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2350\/09-10-0727-CR.1","article-title":"NUT midline carcinoma in a newborn with multiorgan disseminated tumor and a 2-year-old with a pancreatic\/hepatic primary","volume":"13","author":"Shehata","year":"2010","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jmg.2004.029686","article-title":"Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro","volume":"42","author":"Haruki","year":"2005","journal-title":"J. Med. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1101\/gad.267583.115","article-title":"The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains","volume":"29","author":"Alekseyenko","year":"2015","journal-title":"Genes Dev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pin.12727","article-title":"NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment","volume":"68","author":"French","year":"2018","journal-title":"Pathol. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-13-2658","article-title":"Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma","volume":"74","author":"Wang","year":"2014","journal-title":"Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1101\/gr.246520.118","article-title":"High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma","volume":"29","author":"Johnston","year":"2019","journal-title":"Genome Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccell.2019.07.009","article-title":"Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse","volume":"36","author":"Zhang","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-019-1158-7","article-title":"Childhood cerebellar tumours mirror conserved fetal transcriptional programs","volume":"572","author":"Vladoiu","year":"2019","journal-title":"Nature"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1073\/pnas.92.16.7376","article-title":"Cre-mediated site-specific translocation between nonhomologous mouse chromosomes","volume":"92","author":"Fornerod","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1535-6108(03)00106-5","article-title":"Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer","volume":"3","author":"Forster","year":"2003","journal-title":"Cancer Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.genom.7.080505.115741","article-title":"Mouse chromosome engineering for modeling human disease","volume":"7","author":"Bradley","year":"2006","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.cell.2013.08.022","article-title":"One-step generation of mice carrying reporter and conditional alleles by CRISPR\/Cas-mediated genome engineering","volume":"154","author":"Yang","year":"2013","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1152\/physrev.00038.2009","article-title":"Fluorescent proteins and their applications in imaging living cells and tissues","volume":"90","author":"Chudakov","year":"2010","journal-title":"Physiol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/ilar.49.1.103","article-title":"Noninvasive bioluminescence imaging in small animals","volume":"49","author":"Zinn","year":"2008","journal-title":"ILAR J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7150\/thno.3677","article-title":"Positron emission tomography reporter genes and reporter probes: Gene and cell therapy applications","volume":"2","author":"Yaghoubi","year":"2012","journal-title":"Theranostics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nbt.4166","article-title":"Efficient generation of targeted large insertions by microinjection into two-cell-stage mouse embryos","volume":"36","author":"Gu","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13059-017-1220-4","article-title":"Easi-CRISPR: A robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins","volume":"18","author":"Quadros","year":"2017","journal-title":"Genome Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jncimonographs\/lgn022","article-title":"Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias","volume":"39","author":"Lobato","year":"2008","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: Model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.3802","article-title":"Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids","volume":"21","author":"Matano","year":"2015","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","article-title":"A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis","volume":"18","author":"Fujii","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-019-0255-2","article-title":"Organoid models of gastrointestinal cancers in basic and translational research","volume":"17","author":"Lau","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.stem.2018.08.008","article-title":"Esophageal Organoids from Human Pluripotent Stem Cells Delineate Sox2 Functions during Esophageal Specification","volume":"23","author":"Trisno","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e05098","DOI":"10.7554\/eLife.05098","article-title":"In vitro generation of human pluripotent stem cell derived lung organoids","volume":"4","author":"Dye","year":"2015","journal-title":"eLife"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/20974","article-title":"Structure and ligand of a histone acetyltransferase bromodomain","volume":"399","author":"Dhalluin","year":"1999","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1073\/pnas.1433065100","article-title":"The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis","volume":"100","author":"Dey","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature08397","article-title":"Cooperative binding of two acetylation marks on a histone tail by a single bromodomain","volume":"461","author":"Moriniere","year":"2009","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/emboj.2010.176","article-title":"Oncogenesis by sequestration of CBP\/p300 in transcriptionally inactive hyperacetylated chromatin domains","volume":"29","author":"Reynoird","year":"2010","journal-title":"EMBO J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbagrm.2013.08.004","article-title":"Chromatin dynamics during spermiogenesis","volume":"1839","author":"Rathke","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.celrep.2018.08.069","article-title":"Nut Directs p300-Dependent, Genome-Wide H4 Hyperacetylation in Male Germ Cells","volume":"24","author":"Shiota","year":"2018","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev-cellbio-100913-013325","article-title":"Liquid-liquid phase separation in biology","volume":"30","author":"Hyman","year":"2014","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2016.11.054","article-title":"Spatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets","volume":"168","author":"Shin","year":"2017","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1101\/gad.331520.119","article-title":"Evaluating phase separation in live cells: Diagnosis, caveats, and functional consequences","volume":"33","author":"McSwiggen","year":"2019","journal-title":"Genes Dev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-genet-112618-043527","article-title":"Liquid-Liquid Phase Separation in Disease","volume":"53","author":"Alberti","year":"2019","journal-title":"Annu. Rev. Genet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/0008-5472.CAN-10-3513","article-title":"Differentiation of NUT midline carcinoma by epigenomic reprogramming","volume":"71","author":"Schwartz","year":"2011","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/onc.2013.126","article-title":"MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma","volume":"33","author":"Grayson","year":"2014","journal-title":"Oncogene"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1038\/s41388-020-1301-9","article-title":"Therapeutic targeting of p300\/CBP HAT domain for the treatment of NUT midline carcinoma","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s12276-020-0420-2","article-title":"Single-cell multiomics: Technologies and data analysis methods","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cell.2019.05.029","article-title":"Single-Molecule Nanoscopy Elucidates RNA Polymerase II Transcription at Single Genes in Live Cells","volume":"178","author":"Li","year":"2019","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e02230","DOI":"10.7554\/eLife.02230","article-title":"Single-molecule tracking in live cells reveals distinct target-search strategies of transcription factors in the nucleus","volume":"3","author":"Izeddin","year":"2014","journal-title":"eLife"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1038\/ncomms14725","article-title":"Live cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9","volume":"8","author":"Qin","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1002\/cncr.30242","article-title":"Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck","volume":"122","author":"Chau","year":"2016","journal-title":"Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00405-018-4882-y","article-title":"Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: A systematic review and individual patient data analysis of 119 cases","volume":"275","author":"Giridhar","year":"2018","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/1538-7445.AM2019-1191","article-title":"Abstract 1191: PD-L1 expression and the tumor immune microenvironment in NUT carcinoma","volume":"79","author":"Rooper","year":"2019","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/annonc\/mdv209","article-title":"Combining immunotherapy and anticancer agents: The right path to achieve cancer cure?","volume":"26","author":"Apetoh","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"100644","DOI":"10.1016\/j.drup.2019.100644","article-title":"Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer","volume":"46","author":"Leonetti","year":"2019","journal-title":"Drug Resist Updat"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/pbc.25350","article-title":"Histone deacetylase inhibitor for NUT midline carcinoma","volume":"62","author":"Maher","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","article-title":"Clinical Toxicities of Histone Deacetylase Inhibitors","volume":"3","author":"Subramanian","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"Guilhot","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1056\/NEJMoa1609324","article-title":"Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia","volume":"376","author":"Hochhaus","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","article-title":"BET Proteins as Targets for Anticancer Treatment","volume":"8","author":"Stathis","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/2159-8290.CD-15-1335","article-title":"Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015\/MK-8628","volume":"6","author":"Stathis","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","article-title":"BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment","volume":"67","author":"Winter","year":"2017","journal-title":"Mol Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cell.2019.11.031","article-title":"Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery","volume":"181","author":"Burslem","year":"2020","journal-title":"Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.7150\/thno.43360","article-title":"Advances in CRISPR\/Cas-based Gene Therapy in Human Genetic Diseases","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","article-title":"The dTAG system for immediate and target-specific protein degradation","volume":"14","author":"Nabet","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1038\/s41467-020-19532-z","article-title":"The auxin-inducible degron 2 technology provides sharp degradation control in yeast, mammalian cells, and mice","volume":"11","author":"Yesbolatova","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nmeth.1401","article-title":"An auxin-based degron system for the rapid depletion of proteins in nonplant cells","volume":"6","author":"Nishimura","year":"2009","journal-title":"Nat. Methods"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/2\/235\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:20:13Z","timestamp":1760160013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/2\/235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["genes12020235"],"URL":"https:\/\/doi.org\/10.3390\/genes12020235","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,5]]}}}